nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Fluorouracil—stomach cancer	0.13	0.199	CbGbCtD
Sildenafil—ABCC10—Docetaxel—stomach cancer	0.0993	0.152	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—stomach cancer	0.074	0.113	CbGbCtD
Sildenafil—ABCC10—Methotrexate—stomach cancer	0.0717	0.11	CbGbCtD
Sildenafil—ABCC4—Fluorouracil—stomach cancer	0.0625	0.0957	CbGbCtD
Sildenafil—ABCC4—Methotrexate—stomach cancer	0.0345	0.0528	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0259	0.0396	CbGbCtD
Sildenafil—CYP3A7—Irinotecan—stomach cancer	0.0259	0.0396	CbGbCtD
Sildenafil—CYP2C9—Capecitabine—stomach cancer	0.0211	0.0323	CbGbCtD
Sildenafil—CYP3A5—Irinotecan—stomach cancer	0.0194	0.0297	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.019	0.029	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—stomach cancer	0.019	0.029	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—stomach cancer	0.0142	0.0218	CbGbCtD
Sildenafil—CYP2C9—Fluorouracil—stomach cancer	0.0125	0.0191	CbGbCtD
Sildenafil—CYP3A4—Irinotecan—stomach cancer	0.00756	0.0116	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—stomach cancer	0.0065	0.00996	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—stomach cancer	0.00554	0.00849	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—stomach cancer	0.00413	0.00633	CbGbCtD
Sildenafil—PDE5A—blood vessel—stomach cancer	0.00295	0.0591	CbGeAlD
Sildenafil—PDE6H—endocrine gland—stomach cancer	0.00237	0.0475	CbGeAlD
Sildenafil—PDE6G—liver—stomach cancer	0.00206	0.0412	CbGeAlD
Sildenafil—ADORA2A—hematopoietic system—stomach cancer	0.00172	0.0345	CbGeAlD
Sildenafil—PDE6G—lymph node—stomach cancer	0.00158	0.0316	CbGeAlD
Sildenafil—PDE5A—hematopoietic system—stomach cancer	0.00157	0.0314	CbGeAlD
Sildenafil—PDE5A—epithelium—stomach cancer	0.00144	0.0287	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—stomach cancer	0.00138	0.0277	CbGeAlD
Sildenafil—ADORA2A—lymphoid tissue—stomach cancer	0.00121	0.0243	CbGeAlD
Sildenafil—ABCC10—hematopoietic system—stomach cancer	0.0012	0.024	CbGeAlD
Sildenafil—PDE5A—digestive system—stomach cancer	0.00109	0.0219	CbGeAlD
Sildenafil—CYP3A7—endocrine gland—stomach cancer	0.00106	0.0213	CbGeAlD
Sildenafil—ABCC4—hematopoietic system—stomach cancer	0.000995	0.0199	CbGeAlD
Sildenafil—ADORA2A—endocrine gland—stomach cancer	0.000991	0.0198	CbGeAlD
Sildenafil—CYP3A7—liver—stomach cancer	0.00096	0.0192	CbGeAlD
Sildenafil—ABCC5—bone marrow—stomach cancer	0.000921	0.0184	CbGeAlD
Sildenafil—PDE5A—endocrine gland—stomach cancer	0.000902	0.0181	CbGeAlD
Sildenafil—ADORA2A—liver—stomach cancer	0.000893	0.0179	CbGeAlD
Sildenafil—ABCC10—lymphoid tissue—stomach cancer	0.000845	0.0169	CbGeAlD
Sildenafil—ABCC10—digestive system—stomach cancer	0.000835	0.0167	CbGeAlD
Sildenafil—CYP2C19—hematopoietic system—stomach cancer	0.000828	0.0166	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—liver—stomach cancer	0.000816	0.0164	CbGeAlD
Sildenafil—ABCC4—pancreas—stomach cancer	0.000811	0.0162	CbGeAlD
Sildenafil—ABCC10—bone marrow—stomach cancer	0.000769	0.0154	CbGeAlD
Sildenafil—ABCC5—liver—stomach cancer	0.000744	0.0149	CbGeAlD
Sildenafil—ABCC4—digestive system—stomach cancer	0.000692	0.0139	CbGeAlD
Sildenafil—ABCC10—endocrine gland—stomach cancer	0.00069	0.0138	CbGeAlD
Sildenafil—CYP1A1—hematopoietic system—stomach cancer	0.000667	0.0134	CbGeAlD
Sildenafil—CYP3A5—hematopoietic system—stomach cancer	0.000652	0.0131	CbGeAlD
Sildenafil—CYP2C9—hematopoietic system—stomach cancer	0.000642	0.0129	CbGeAlD
Sildenafil—ABCC4—bone marrow—stomach cancer	0.000638	0.0128	CbGeAlD
Sildenafil—PDE5A—lymph node—stomach cancer	0.000624	0.0125	CbGeAlD
Sildenafil—ABCC10—liver—stomach cancer	0.000622	0.0125	CbGeAlD
Sildenafil—CYP1A1—epithelium—stomach cancer	0.00061	0.0122	CbGeAlD
Sildenafil—CYP2E1—hematopoietic system—stomach cancer	0.000608	0.0122	CbGeAlD
Sildenafil—CYP2C19—digestive system—stomach cancer	0.000576	0.0115	CbGeAlD
Sildenafil—ABCC4—endocrine gland—stomach cancer	0.000572	0.0115	CbGeAlD
Sildenafil—ABCC5—lymph node—stomach cancer	0.00057	0.0114	CbGeAlD
Sildenafil—CYP3A5—pancreas—stomach cancer	0.000531	0.0106	CbGeAlD
Sildenafil—ABCC4—liver—stomach cancer	0.000516	0.0103	CbGeAlD
Sildenafil—CYP3A4—hematopoietic system—stomach cancer	0.000489	0.0098	CbGeAlD
Sildenafil—CYP2D6—hematopoietic system—stomach cancer	0.000482	0.00965	CbGeAlD
Sildenafil—ABCC10—lymph node—stomach cancer	0.000477	0.00955	CbGeAlD
Sildenafil—CYP2C19—endocrine gland—stomach cancer	0.000476	0.00953	CbGeAlD
Sildenafil—CYP1A1—digestive system—stomach cancer	0.000464	0.00929	CbGeAlD
Sildenafil—CYP3A5—digestive system—stomach cancer	0.000454	0.00908	CbGeAlD
Sildenafil—CYP2C9—digestive system—stomach cancer	0.000446	0.00894	CbGeAlD
Sildenafil—CYP2C19—liver—stomach cancer	0.000429	0.00859	CbGeAlD
Sildenafil—CYP2E1—lymphoid tissue—stomach cancer	0.000428	0.00858	CbGeAlD
Sildenafil—CYP2E1—digestive system—stomach cancer	0.000423	0.00847	CbGeAlD
Sildenafil—ABCC4—lymph node—stomach cancer	0.000395	0.00792	CbGeAlD
Sildenafil—CYP1A1—endocrine gland—stomach cancer	0.000383	0.00768	CbGeAlD
Sildenafil—CYP3A5—endocrine gland—stomach cancer	0.000375	0.00751	CbGeAlD
Sildenafil—CYP2C9—endocrine gland—stomach cancer	0.000369	0.00739	CbGeAlD
Sildenafil—CYP2E1—endocrine gland—stomach cancer	0.00035	0.007	CbGeAlD
Sildenafil—CYP1A1—liver—stomach cancer	0.000346	0.00692	CbGeAlD
Sildenafil—CYP3A4—digestive system—stomach cancer	0.00034	0.00682	CbGeAlD
Sildenafil—CYP3A5—liver—stomach cancer	0.000338	0.00677	CbGeAlD
Sildenafil—CYP2D6—digestive system—stomach cancer	0.000335	0.00671	CbGeAlD
Sildenafil—CYP2C9—liver—stomach cancer	0.000333	0.00666	CbGeAlD
Sildenafil—CYP2E1—liver—stomach cancer	0.000315	0.00631	CbGeAlD
Sildenafil—CYP3A4—endocrine gland—stomach cancer	0.000281	0.00563	CbGeAlD
Sildenafil—CYP2D6—endocrine gland—stomach cancer	0.000277	0.00554	CbGeAlD
Sildenafil—CYP1A1—lymph node—stomach cancer	0.000265	0.00531	CbGeAlD
Sildenafil—CYP3A4—liver—stomach cancer	0.000254	0.00508	CbGeAlD
Sildenafil—CYP2D6—liver—stomach cancer	0.00025	0.005	CbGeAlD
Sildenafil—Malnutrition—Methotrexate—stomach cancer	9.11e-05	0.000424	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—stomach cancer	9.11e-05	0.000424	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.1e-05	0.000423	CcSEcCtD
Sildenafil—Flushing—Epirubicin—stomach cancer	9.09e-05	0.000423	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—stomach cancer	9.09e-05	0.000423	CcSEcCtD
Sildenafil—Vomiting—Fluorouracil—stomach cancer	9.09e-05	0.000423	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—stomach cancer	9.09e-05	0.000423	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—stomach cancer	9.08e-05	0.000423	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—stomach cancer	9.07e-05	0.000422	CcSEcCtD
Sildenafil—Insomnia—Capecitabine—stomach cancer	9.04e-05	0.00042	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—stomach cancer	9.02e-05	0.00042	CcSEcCtD
Sildenafil—Rash—Fluorouracil—stomach cancer	9.02e-05	0.000419	CcSEcCtD
Sildenafil—Dermatitis—Fluorouracil—stomach cancer	9.01e-05	0.000419	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—stomach cancer	9e-05	0.000419	CcSEcCtD
Sildenafil—Paraesthesia—Capecitabine—stomach cancer	8.97e-05	0.000417	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—stomach cancer	8.97e-05	0.000417	CcSEcCtD
Sildenafil—Headache—Fluorouracil—stomach cancer	8.96e-05	0.000417	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—stomach cancer	8.95e-05	0.000416	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—stomach cancer	8.93e-05	0.000415	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—stomach cancer	8.91e-05	0.000414	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—stomach cancer	8.91e-05	0.000414	CcSEcCtD
Sildenafil—Dyspnoea—Capecitabine—stomach cancer	8.91e-05	0.000414	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—stomach cancer	8.9e-05	0.000414	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—stomach cancer	8.89e-05	0.000413	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—stomach cancer	8.89e-05	0.000413	CcSEcCtD
Sildenafil—Nausea—Irinotecan—stomach cancer	8.87e-05	0.000412	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—stomach cancer	8.85e-05	0.000412	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—stomach cancer	8.83e-05	0.000411	CcSEcCtD
Sildenafil—Constipation—Docetaxel—stomach cancer	8.82e-05	0.000411	CcSEcCtD
Sildenafil—Pain—Docetaxel—stomach cancer	8.82e-05	0.000411	CcSEcCtD
Sildenafil—Back pain—Methotrexate—stomach cancer	8.82e-05	0.00041	CcSEcCtD
Sildenafil—Dyspepsia—Capecitabine—stomach cancer	8.8e-05	0.000409	CcSEcCtD
Sildenafil—Chills—Epirubicin—stomach cancer	8.79e-05	0.000409	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—stomach cancer	8.75e-05	0.000407	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—stomach cancer	8.74e-05	0.000406	CcSEcCtD
Sildenafil—Decreased appetite—Capecitabine—stomach cancer	8.69e-05	0.000404	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—stomach cancer	8.66e-05	0.000403	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Capecitabine—stomach cancer	8.63e-05	0.000401	CcSEcCtD
Sildenafil—Fatigue—Capecitabine—stomach cancer	8.61e-05	0.000401	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—stomach cancer	8.59e-05	0.0004	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—stomach cancer	8.58e-05	0.000399	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—stomach cancer	8.57e-05	0.000399	CcSEcCtD
Sildenafil—Pain—Capecitabine—stomach cancer	8.54e-05	0.000397	CcSEcCtD
Sildenafil—Constipation—Capecitabine—stomach cancer	8.54e-05	0.000397	CcSEcCtD
Sildenafil—Erythema—Epirubicin—stomach cancer	8.53e-05	0.000397	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—stomach cancer	8.53e-05	0.000397	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—stomach cancer	8.5e-05	0.000396	CcSEcCtD
Sildenafil—Nausea—Fluorouracil—stomach cancer	8.49e-05	0.000395	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—stomach cancer	8.47e-05	0.000394	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—stomach cancer	8.46e-05	0.000393	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—stomach cancer	8.45e-05	0.000393	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—stomach cancer	8.44e-05	0.000393	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—stomach cancer	8.42e-05	0.000392	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—stomach cancer	8.41e-05	0.000391	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—stomach cancer	8.41e-05	0.000391	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—stomach cancer	8.4e-05	0.000391	CcSEcCtD
Sildenafil—Tension—Epirubicin—stomach cancer	8.37e-05	0.000389	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—stomach cancer	8.28e-05	0.000385	CcSEcCtD
Sildenafil—Back pain—Epirubicin—stomach cancer	8.25e-05	0.000384	CcSEcCtD
Sildenafil—Feeling abnormal—Capecitabine—stomach cancer	8.23e-05	0.000383	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—stomach cancer	8.22e-05	0.000383	CcSEcCtD
Sildenafil—Malaise—Methotrexate—stomach cancer	8.22e-05	0.000382	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—stomach cancer	8.19e-05	0.000381	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—stomach cancer	8.19e-05	0.000381	CcSEcCtD
Sildenafil—Gastrointestinal pain—Capecitabine—stomach cancer	8.17e-05	0.00038	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—stomach cancer	8.17e-05	0.00038	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—stomach cancer	8.16e-05	0.000379	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—stomach cancer	8.16e-05	0.000379	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—stomach cancer	8.16e-05	0.000379	CcSEcCtD
Sildenafil—Chills—Doxorubicin—stomach cancer	8.13e-05	0.000378	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—stomach cancer	8.1e-05	0.000377	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—stomach cancer	8.04e-05	0.000374	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—stomach cancer	8.01e-05	0.000373	CcSEcCtD
Sildenafil—Cough—Methotrexate—stomach cancer	7.95e-05	0.00037	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—stomach cancer	7.94e-05	0.000369	CcSEcCtD
Sildenafil—Urticaria—Capecitabine—stomach cancer	7.94e-05	0.000369	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—stomach cancer	7.91e-05	0.000368	CcSEcCtD
Sildenafil—Abdominal pain—Capecitabine—stomach cancer	7.9e-05	0.000367	CcSEcCtD
Sildenafil—Body temperature increased—Capecitabine—stomach cancer	7.9e-05	0.000367	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—stomach cancer	7.9e-05	0.000367	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—stomach cancer	7.89e-05	0.000367	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—stomach cancer	7.89e-05	0.000367	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—stomach cancer	7.88e-05	0.000367	CcSEcCtD
Sildenafil—Agitation—Epirubicin—stomach cancer	7.84e-05	0.000365	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—stomach cancer	7.78e-05	0.000362	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—stomach cancer	7.76e-05	0.000361	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—stomach cancer	7.76e-05	0.000361	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—stomach cancer	7.76e-05	0.000361	CcSEcCtD
Sildenafil—Tension—Doxorubicin—stomach cancer	7.74e-05	0.00036	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.71e-05	0.000358	CcSEcCtD
Sildenafil—Malaise—Epirubicin—stomach cancer	7.69e-05	0.000358	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—stomach cancer	7.67e-05	0.000357	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—stomach cancer	7.66e-05	0.000357	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—stomach cancer	7.66e-05	0.000356	CcSEcCtD
Sildenafil—Syncope—Epirubicin—stomach cancer	7.65e-05	0.000356	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—stomach cancer	7.63e-05	0.000355	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—stomach cancer	7.63e-05	0.000355	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—stomach cancer	7.6e-05	0.000354	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—stomach cancer	7.54e-05	0.000351	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—stomach cancer	7.5e-05	0.000349	CcSEcCtD
Sildenafil—Cough—Epirubicin—stomach cancer	7.44e-05	0.000346	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—stomach cancer	7.44e-05	0.000346	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—stomach cancer	7.4e-05	0.000344	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—stomach cancer	7.39e-05	0.000344	CcSEcCtD
Sildenafil—Infection—Methotrexate—stomach cancer	7.39e-05	0.000344	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—stomach cancer	7.36e-05	0.000343	CcSEcCtD
Sildenafil—Hypersensitivity—Capecitabine—stomach cancer	7.36e-05	0.000342	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—stomach cancer	7.32e-05	0.000341	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—stomach cancer	7.3e-05	0.00034	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—stomach cancer	7.29e-05	0.000339	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—stomach cancer	7.29e-05	0.000339	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—stomach cancer	7.26e-05	0.000338	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—stomach cancer	7.26e-05	0.000338	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—stomach cancer	7.26e-05	0.000338	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—stomach cancer	7.25e-05	0.000337	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—stomach cancer	7.24e-05	0.000337	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—stomach cancer	7.22e-05	0.000336	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.21e-05	0.000335	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—stomach cancer	7.19e-05	0.000334	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—stomach cancer	7.17e-05	0.000334	CcSEcCtD
Sildenafil—Asthenia—Capecitabine—stomach cancer	7.17e-05	0.000333	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—stomach cancer	7.12e-05	0.000331	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—stomach cancer	7.1e-05	0.00033	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—stomach cancer	7.09e-05	0.00033	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—stomach cancer	7.09e-05	0.00033	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—stomach cancer	7.08e-05	0.000329	CcSEcCtD
Sildenafil—Pruritus—Capecitabine—stomach cancer	7.07e-05	0.000329	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—stomach cancer	7.06e-05	0.000329	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—stomach cancer	7.06e-05	0.000328	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—stomach cancer	6.97e-05	0.000324	CcSEcCtD
Sildenafil—Oedema—Epirubicin—stomach cancer	6.96e-05	0.000324	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—stomach cancer	6.95e-05	0.000323	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—stomach cancer	6.94e-05	0.000323	CcSEcCtD
Sildenafil—Infection—Epirubicin—stomach cancer	6.92e-05	0.000322	CcSEcCtD
Sildenafil—Cough—Doxorubicin—stomach cancer	6.89e-05	0.00032	CcSEcCtD
Sildenafil—Shock—Epirubicin—stomach cancer	6.85e-05	0.000319	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—stomach cancer	6.84e-05	0.000318	CcSEcCtD
Sildenafil—Diarrhoea—Capecitabine—stomach cancer	6.84e-05	0.000318	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—stomach cancer	6.83e-05	0.000318	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—stomach cancer	6.82e-05	0.000317	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—stomach cancer	6.81e-05	0.000317	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—stomach cancer	6.79e-05	0.000316	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.78e-05	0.000315	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—stomach cancer	6.76e-05	0.000315	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—stomach cancer	6.73e-05	0.000313	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—stomach cancer	6.73e-05	0.000313	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—stomach cancer	6.72e-05	0.000313	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—stomach cancer	6.72e-05	0.000313	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—stomach cancer	6.72e-05	0.000313	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—stomach cancer	6.7e-05	0.000311	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—stomach cancer	6.68e-05	0.000311	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.67e-05	0.00031	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—stomach cancer	6.64e-05	0.000309	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—stomach cancer	6.63e-05	0.000309	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—stomach cancer	6.63e-05	0.000308	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—stomach cancer	6.61e-05	0.000308	CcSEcCtD
Sildenafil—Dizziness—Capecitabine—stomach cancer	6.61e-05	0.000307	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—stomach cancer	6.57e-05	0.000306	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—stomach cancer	6.56e-05	0.000305	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—stomach cancer	6.55e-05	0.000305	CcSEcCtD
Sildenafil—Rash—Docetaxel—stomach cancer	6.51e-05	0.000303	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—stomach cancer	6.5e-05	0.000303	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—stomach cancer	6.5e-05	0.000302	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—stomach cancer	6.47e-05	0.000301	CcSEcCtD
Sildenafil—Headache—Docetaxel—stomach cancer	6.46e-05	0.000301	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—stomach cancer	6.44e-05	0.0003	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—stomach cancer	6.42e-05	0.000299	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—stomach cancer	6.41e-05	0.000298	CcSEcCtD
Sildenafil—Infection—Doxorubicin—stomach cancer	6.4e-05	0.000298	CcSEcCtD
Sildenafil—Pain—Methotrexate—stomach cancer	6.36e-05	0.000296	CcSEcCtD
Sildenafil—Vomiting—Capecitabine—stomach cancer	6.35e-05	0.000296	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.34e-05	0.000295	CcSEcCtD
Sildenafil—Shock—Doxorubicin—stomach cancer	6.34e-05	0.000295	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—stomach cancer	6.32e-05	0.000294	CcSEcCtD
Sildenafil—Rash—Capecitabine—stomach cancer	6.3e-05	0.000293	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—stomach cancer	6.3e-05	0.000293	CcSEcCtD
Sildenafil—Dermatitis—Capecitabine—stomach cancer	6.29e-05	0.000293	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—stomach cancer	6.29e-05	0.000292	CcSEcCtD
Sildenafil—Headache—Capecitabine—stomach cancer	6.26e-05	0.000291	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—stomach cancer	6.26e-05	0.000291	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—stomach cancer	6.25e-05	0.000291	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—stomach cancer	6.23e-05	0.00029	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—stomach cancer	6.21e-05	0.000289	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—stomach cancer	6.19e-05	0.000288	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—stomach cancer	6.14e-05	0.000286	CcSEcCtD
Sildenafil—Nausea—Docetaxel—stomach cancer	6.13e-05	0.000285	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—stomach cancer	6.13e-05	0.000285	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—stomach cancer	6.13e-05	0.000285	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—stomach cancer	6.08e-05	0.000283	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—stomach cancer	6.05e-05	0.000281	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—stomach cancer	6.02e-05	0.00028	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—stomach cancer	6.01e-05	0.00028	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—stomach cancer	6e-05	0.000279	CcSEcCtD
Sildenafil—Constipation—Epirubicin—stomach cancer	5.95e-05	0.000277	CcSEcCtD
Sildenafil—Pain—Epirubicin—stomach cancer	5.95e-05	0.000277	CcSEcCtD
Sildenafil—Nausea—Capecitabine—stomach cancer	5.93e-05	0.000276	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—stomach cancer	5.91e-05	0.000275	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—stomach cancer	5.88e-05	0.000274	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—stomach cancer	5.88e-05	0.000274	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.87e-05	0.000273	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—stomach cancer	5.83e-05	0.000271	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—stomach cancer	5.78e-05	0.000269	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—stomach cancer	5.74e-05	0.000267	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—stomach cancer	5.74e-05	0.000267	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—stomach cancer	5.73e-05	0.000266	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—stomach cancer	5.69e-05	0.000265	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—stomach cancer	5.67e-05	0.000264	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—stomach cancer	5.6e-05	0.00026	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.56e-05	0.000259	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—stomach cancer	5.55e-05	0.000258	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—stomach cancer	5.53e-05	0.000257	CcSEcCtD
Sildenafil—Pain—Doxorubicin—stomach cancer	5.51e-05	0.000256	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—stomach cancer	5.51e-05	0.000256	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—stomach cancer	5.5e-05	0.000256	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—stomach cancer	5.5e-05	0.000256	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—stomach cancer	5.48e-05	0.000255	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—stomach cancer	5.34e-05	0.000248	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—stomach cancer	5.31e-05	0.000247	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—stomach cancer	5.27e-05	0.000245	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—stomach cancer	5.26e-05	0.000245	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—stomach cancer	5.13e-05	0.000239	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—stomach cancer	5.12e-05	0.000238	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—stomach cancer	5.09e-05	0.000237	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—stomach cancer	5.09e-05	0.000237	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—stomach cancer	5.09e-05	0.000237	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—stomach cancer	4.99e-05	0.000232	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—stomach cancer	4.92e-05	0.000229	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—stomach cancer	4.92e-05	0.000229	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—stomach cancer	4.76e-05	0.000222	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—stomach cancer	4.75e-05	0.000221	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—stomach cancer	4.73e-05	0.00022	CcSEcCtD
Sildenafil—Rash—Methotrexate—stomach cancer	4.69e-05	0.000218	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—stomach cancer	4.69e-05	0.000218	CcSEcCtD
Sildenafil—Headache—Methotrexate—stomach cancer	4.66e-05	0.000217	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—stomach cancer	4.62e-05	0.000215	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—stomach cancer	4.6e-05	0.000214	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—stomach cancer	4.56e-05	0.000212	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—stomach cancer	4.43e-05	0.000206	CcSEcCtD
Sildenafil—Nausea—Methotrexate—stomach cancer	4.42e-05	0.000206	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—stomach cancer	4.41e-05	0.000205	CcSEcCtD
Sildenafil—Rash—Epirubicin—stomach cancer	4.39e-05	0.000204	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—stomach cancer	4.38e-05	0.000204	CcSEcCtD
Sildenafil—Headache—Epirubicin—stomach cancer	4.36e-05	0.000203	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—stomach cancer	4.26e-05	0.000198	CcSEcCtD
Sildenafil—Nausea—Epirubicin—stomach cancer	4.13e-05	0.000192	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—stomach cancer	4.09e-05	0.00019	CcSEcCtD
Sildenafil—Rash—Doxorubicin—stomach cancer	4.06e-05	0.000189	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—stomach cancer	4.06e-05	0.000189	CcSEcCtD
Sildenafil—Headache—Doxorubicin—stomach cancer	4.03e-05	0.000188	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—stomach cancer	3.83e-05	0.000178	CcSEcCtD
Sildenafil—ABCC4—Hemostasis—TP53—stomach cancer	1.06e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTT1—stomach cancer	1.05e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTT1—stomach cancer	1.05e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2A6—stomach cancer	1.04e-05	0.000127	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.04e-05	0.000126	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—stomach cancer	1.04e-05	0.000126	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1.03e-05	0.000125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IRS2—stomach cancer	1.02e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.02e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1C3—stomach cancer	1.01e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.01e-05	0.000123	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—stomach cancer	1.01e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—stomach cancer	1.01e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALDOB—stomach cancer	1.01e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SREBF2—stomach cancer	9.99e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—stomach cancer	9.95e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTT1—stomach cancer	9.94e-06	0.000121	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CAV1—stomach cancer	9.92e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SREBF2—stomach cancer	9.91e-06	0.00012	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOA1—stomach cancer	9.89e-06	0.00012	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—stomach cancer	9.88e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ENO1—stomach cancer	9.88e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RORA—stomach cancer	9.87e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ENO1—stomach cancer	9.86e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2A6—stomach cancer	9.83e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FBP1—stomach cancer	9.79e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.79e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA1—stomach cancer	9.79e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CKB—stomach cancer	9.79e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RORA—stomach cancer	9.79e-06	0.000119	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—stomach cancer	9.66e-06	0.000117	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—stomach cancer	9.56e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1C3—stomach cancer	9.56e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.48e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.46e-06	0.000115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PRKCB—stomach cancer	9.44e-06	0.000115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6ST—stomach cancer	9.4e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TYMS—stomach cancer	9.38e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALOX5—stomach cancer	9.35e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ENO1—stomach cancer	9.32e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—stomach cancer	9.27e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDOB—stomach cancer	9.25e-06	0.000112	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—stomach cancer	9.23e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLIN2—stomach cancer	9.21e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DPYD—stomach cancer	9.2e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDOB—stomach cancer	9.17e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.16e-06	0.000111	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—stomach cancer	9.14e-06	0.000111	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—stomach cancer	9.03e-06	0.00011	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—stomach cancer	8.98e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA2—stomach cancer	8.95e-06	0.000109	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—stomach cancer	8.78e-06	0.000107	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—stomach cancer	8.78e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CD44—stomach cancer	8.76e-06	0.000106	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—stomach cancer	8.75e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CD44—stomach cancer	8.74e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PGAM1—stomach cancer	8.73e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NT5E—stomach cancer	8.73e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ERCC2—stomach cancer	8.72e-06	0.000106	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—stomach cancer	8.65e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.65e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.63e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALOX5—stomach cancer	8.6e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALOX5—stomach cancer	8.53e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DPYD—stomach cancer	8.46e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DPYD—stomach cancer	8.39e-06	0.000102	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6R—stomach cancer	8.39e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.34e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.32e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLCE1—stomach cancer	8.32e-06	0.000101	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—stomach cancer	8.3e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CD44—stomach cancer	8.26e-06	0.0001	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—stomach cancer	8.23e-06	0.0001	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—stomach cancer	8.23e-06	0.0001	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—stomach cancer	8.19e-06	9.96e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTT1—stomach cancer	8.14e-06	9.88e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2A6—stomach cancer	8.04e-06	9.77e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.02e-06	9.74e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—UMPS—stomach cancer	7.98e-06	9.7e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—stomach cancer	7.86e-06	9.56e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SERPINE1—stomach cancer	7.85e-06	9.54e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1C3—stomach cancer	7.82e-06	9.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—stomach cancer	7.77e-06	9.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ENO1—stomach cancer	7.62e-06	9.26e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—stomach cancer	7.62e-06	9.26e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.6e-06	9.24e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RHOA—stomach cancer	7.58e-06	9.2e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAV1—stomach cancer	7.56e-06	9.18e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOA1—stomach cancer	7.54e-06	9.16e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOS3—stomach cancer	7.5e-06	9.11e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.5e-06	9.11e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—stomach cancer	7.48e-06	9.09e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPP2R1A—stomach cancer	7.45e-06	9.05e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPP2R1A—stomach cancer	7.44e-06	9.03e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PDHA1—stomach cancer	7.42e-06	9.01e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ECHS1—stomach cancer	7.42e-06	9.01e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—stomach cancer	7.42e-06	9.01e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2A6—stomach cancer	7.4e-06	8.99e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2A6—stomach cancer	7.33e-06	8.91e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—stomach cancer	7.31e-06	8.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—stomach cancer	7.29e-06	8.86e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—stomach cancer	7.21e-06	8.76e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C3—stomach cancer	7.19e-06	8.74e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—stomach cancer	7.19e-06	8.74e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—stomach cancer	7.14e-06	8.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C3—stomach cancer	7.13e-06	8.67e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—stomach cancer	7.05e-06	8.57e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPP2R1A—stomach cancer	7.02e-06	8.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—stomach cancer	7.01e-06	8.52e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ENO1—stomach cancer	7.01e-06	8.52e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMP—stomach cancer	6.98e-06	8.48e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FADS1—stomach cancer	6.98e-06	8.48e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ENO1—stomach cancer	6.95e-06	8.44e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—stomach cancer	6.89e-06	8.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.84e-06	8.31e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—stomach cancer	6.8e-06	8.26e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—stomach cancer	6.79e-06	8.26e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—stomach cancer	6.78e-06	8.24e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CD44—stomach cancer	6.76e-06	8.21e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—stomach cancer	6.75e-06	8.2e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—stomach cancer	6.72e-06	8.16e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—stomach cancer	6.7e-06	8.14e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—stomach cancer	6.65e-06	8.08e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—stomach cancer	6.64e-06	8.07e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—stomach cancer	6.61e-06	8.03e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.56e-06	7.97e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SREBF2—stomach cancer	6.53e-06	7.94e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—stomach cancer	6.5e-06	7.89e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RORA—stomach cancer	6.45e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—stomach cancer	6.41e-06	7.78e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—stomach cancer	6.38e-06	7.76e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—stomach cancer	6.33e-06	7.69e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—stomach cancer	6.32e-06	7.68e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ERCC2—stomach cancer	6.31e-06	7.67e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ERCC2—stomach cancer	6.3e-06	7.66e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CD44—stomach cancer	6.22e-06	7.55e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—stomach cancer	6.2e-06	7.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—stomach cancer	6.18e-06	7.51e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CD44—stomach cancer	6.16e-06	7.49e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDOB—stomach cancer	6.05e-06	7.35e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—stomach cancer	6.02e-06	7.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—stomach cancer	5.99e-06	7.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.98e-06	7.27e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—stomach cancer	5.97e-06	7.26e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ERCC2—stomach cancer	5.95e-06	7.23e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—stomach cancer	5.94e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—stomach cancer	5.92e-06	7.2e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK8—stomach cancer	5.85e-06	7.11e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.75e-06	6.98e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NOS3—stomach cancer	5.72e-06	6.94e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—stomach cancer	5.64e-06	6.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALOX5—stomach cancer	5.62e-06	6.83e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—stomach cancer	5.6e-06	6.8e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—stomach cancer	5.56e-06	6.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DPYD—stomach cancer	5.53e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAV1—stomach cancer	5.48e-06	6.65e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAV1—stomach cancer	5.46e-06	6.64e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOA1—stomach cancer	5.46e-06	6.64e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOA1—stomach cancer	5.45e-06	6.62e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—stomach cancer	5.4e-06	6.56e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—stomach cancer	5.35e-06	6.5e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPP2R1A—stomach cancer	5.29e-06	6.42e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—stomach cancer	5.24e-06	6.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.24e-06	6.37e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—stomach cancer	5.23e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—stomach cancer	5.19e-06	6.3e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—stomach cancer	5.18e-06	6.3e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAV1—stomach cancer	5.16e-06	6.27e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOA1—stomach cancer	5.15e-06	6.26e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—stomach cancer	5.14e-06	6.25e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—stomach cancer	5.11e-06	6.21e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—stomach cancer	5.11e-06	6.21e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—stomach cancer	5.07e-06	6.16e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—stomach cancer	4.97e-06	6.04e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.93e-06	5.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—stomach cancer	4.89e-06	5.94e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ERCC2—stomach cancer	4.87e-06	5.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—stomach cancer	4.86e-06	5.91e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—stomach cancer	4.86e-06	5.91e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.84e-06	5.88e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—stomach cancer	4.82e-06	5.86e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—stomach cancer	4.81e-06	5.85e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—stomach cancer	4.8e-06	5.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—stomach cancer	4.78e-06	5.81e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—stomach cancer	4.77e-06	5.79e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—stomach cancer	4.72e-06	5.74e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.7e-06	5.72e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—stomach cancer	4.59e-06	5.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO1—stomach cancer	4.58e-06	5.57e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—stomach cancer	4.58e-06	5.56e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—stomach cancer	4.54e-06	5.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ERCC2—stomach cancer	4.48e-06	5.44e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ERCC2—stomach cancer	4.44e-06	5.4e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—stomach cancer	4.33e-06	5.26e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—stomach cancer	4.32e-06	5.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAV1—stomach cancer	4.22e-06	5.13e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—stomach cancer	4.22e-06	5.13e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOA1—stomach cancer	4.21e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—stomach cancer	4.21e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—stomach cancer	4.18e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NOS3—stomach cancer	4.14e-06	5.03e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NOS3—stomach cancer	4.13e-06	5.02e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—stomach cancer	4.08e-06	4.96e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—stomach cancer	4.08e-06	4.96e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CD44—stomach cancer	4.07e-06	4.94e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.04e-06	4.9e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—stomach cancer	3.9e-06	4.74e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NOS3—stomach cancer	3.9e-06	4.74e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAV1—stomach cancer	3.89e-06	4.72e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOA1—stomach cancer	3.88e-06	4.71e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAV1—stomach cancer	3.85e-06	4.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOA1—stomach cancer	3.84e-06	4.67e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—stomach cancer	3.79e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—stomach cancer	3.78e-06	4.59e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—stomach cancer	3.74e-06	4.54e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—stomach cancer	3.71e-06	4.51e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.68e-06	4.47e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—stomach cancer	3.57e-06	4.34e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.46e-06	4.2e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—stomach cancer	3.42e-06	4.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—stomach cancer	3.39e-06	4.12e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—stomach cancer	3.39e-06	4.11e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—stomach cancer	3.34e-06	4.06e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—stomach cancer	3.34e-06	4.06e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—stomach cancer	3.22e-06	3.91e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NOS3—stomach cancer	3.19e-06	3.88e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—stomach cancer	3.15e-06	3.83e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—stomach cancer	3.12e-06	3.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—stomach cancer	3.07e-06	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—stomach cancer	3.04e-06	3.7e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NOS3—stomach cancer	2.94e-06	3.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ERCC2—stomach cancer	2.93e-06	3.56e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—stomach cancer	2.92e-06	3.55e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NOS3—stomach cancer	2.91e-06	3.54e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—stomach cancer	2.75e-06	3.35e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—stomach cancer	2.69e-06	3.26e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—stomach cancer	2.66e-06	3.24e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAV1—stomach cancer	2.54e-06	3.09e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA1—stomach cancer	2.53e-06	3.08e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—stomach cancer	2.33e-06	2.83e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—stomach cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—stomach cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NOS3—stomach cancer	1.92e-06	2.33e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.8e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—stomach cancer	1.76e-06	2.13e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.65e-06	2.01e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.64e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.08e-06	1.31e-05	CbGpPWpGaD
